Phosphorus-31 magnetic resonance spectroscopy of the human liver using chemical shift imaging techniques.

[1]  S. Cohen,et al.  Application of Nuclear Magnetic Resonance to the Study of Liver Physiology and Disease , 2007, Hepatology.

[2]  D. Gadian,et al.  Saturation effects in phosphorus‐31 magnetic resonance spectra of the human liver , 1991, Magnetic resonance in medicine.

[3]  Jimmy D Bell,et al.  31P Magnetic resonance spectroscopy of the human paediatric liver , 1990, NMR in biomedicine.

[4]  G K Radda,et al.  Study of human liver disease with P-31 magnetic resonance spectroscopy. , 1990, Gut.

[5]  M. Weiner,et al.  Abnormalities of the Liver Evaluated by 31P MRS , 1989, Investigative radiology.

[6]  G. Radda,et al.  Phospholipid bilayer contribution to 31P NMR spectra in vivo , 1989, Magnetic resonance in medicine.

[7]  M W Weiner,et al.  Alcoholic liver disease: quantitative image-guided P-31 MR spectroscopy. , 1989, Radiology.

[8]  D. Gadian,et al.  Phosphodiesters in the Liver: The Effect of Field Strength on the 31P Signal , 1989, Magnetic resonance in medicine.

[9]  T. Chenevert,et al.  Image localized 31P magnetic resonance spectroscopy of the human liver , 1989, NMR in biomedicine.

[10]  P R Luyten,et al.  Broadband proton decoupling in human 31p NMR spectroscopy , 1989, NMR in biomedicine.

[11]  A. S. Hall,et al.  In vivo implementation of three-dimensional phase-encoded spectroscopy with a correction for field inhomogeneity , 1988 .

[12]  A. S. Hall,et al.  Four-dimensional chemical shift MR imaging of phosphorus metabolites of normal and diseased human liver. , 1988 .

[13]  G. Radda,et al.  Study of Liver Metabolism in Glucose-6-Phosphatase Deficiency (Glycogen Storage Disease Type 1A) by P-31 Magnetic Resonance Spectroscopy , 1988, Pediatric Research.

[14]  J. Sargentoni,et al.  Four‐dimensional phosphorus‐31 chemical shift imaging of carcinoid metastases in the liver , 1988, NMR in biomedicine.

[15]  Graeme M. Bydder,et al.  Localized phosphorus-31 NMR spectroscopy of normal and pathological human organs in vivo using phase-encoding techniques , 1987 .

[16]  David Hilton-Jones,et al.  BIOCHEMICAL INVESTIGATION OF HUMAN TUMOURS IN VIVO WITH PHOSPHORUS-31 MAGNETIC RESONANCE SPECTROSCOPY , 1986, The Lancet.

[17]  B. Chance,et al.  31P nuclear magnetic resonance spectroscopic investigation of human neuroblastoma in situ. , 1985, The New England journal of medicine.

[18]  N. Curtin,et al.  Enzymic retrodifferentiation during hepatocarcinogenesis and liver regeneration in rats in vivo. , 1983, British Journal of Cancer.

[19]  D. Gadian,et al.  Bioenergetics of intact human muscle. A 31P nuclear magnetic resonance study. , 1983, Molecular biology & medicine.

[20]  K. Uğurbil,et al.  NMR chemical shift imaging in three dimensions. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R. Sanders,et al.  Activity and some properties of choline kinase, cholinephosphate cytidyltransferase and choline phosphotransferase during liver development in the rat. , 1973, Biochimica et biophysica acta.

[22]  P. Weinhold,et al.  Ethanolamine phosphokinase: activity and properties during liver development. , 1972, Biochimica et biophysica acta.

[23]  G K Radda,et al.  A study of patients with alcoholic liver disease by 31P nuclear magnetic resonance spectroscopy. , 1990, Clinical science.

[24]  J. Tooke,et al.  Postural vasoconstriction in women during the normal menstrual cycle. , 1990, Clinical science.